Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MARKSANS PHARMA. vs THEMIS MEDICARE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MARKSANS PHARMA. THEMIS MEDICARE MARKSANS PHARMA./
THEMIS MEDICARE
 
P/E (TTM) x 21.3 73.5 29.0% View Chart
P/BV x 3.9 6.0 65.3% View Chart
Dividend Yield % 0.3 0.2 146.7%  

Financials

 MARKSANS PHARMA.   THEMIS MEDICARE
EQUITY SHARE DATA
    MARKSANS PHARMA.
Mar-23
THEMIS MEDICARE
Mar-23
MARKSANS PHARMA./
THEMIS MEDICARE
5-Yr Chart
Click to enlarge
High Rs741,434 5.2%   
Low Rs39692 5.6%   
Sales per share (Unadj.) Rs40.9385.1 10.6%  
Earnings per share (Unadj.) Rs5.961.8 9.5%  
Cash flow per share (Unadj.) Rs7.073.3 9.6%  
Dividends per share (Unadj.) Rs0.500.50 100.0%  
Avg Dividend yield %0.90 1,879.6%  
Book value per share (Unadj.) Rs38.5368.9 10.4%  
Shares outstanding (eoy) m453.169.20 4,925.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.42.8 50.1%   
Avg P/E ratio x9.717.2 56.2%  
P/CF ratio (eoy) x8.114.5 55.7%  
Price / Book Value ratio x1.52.9 50.9%  
Dividend payout %8.50.8 1,056.0%   
Avg Mkt Cap Rs m25,6319,784 262.0%   
No. of employees `000NANA-   
Total wages/salary Rs m2,394661 361.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m18,5213,543 522.7%  
Other income Rs m593115 515.5%   
Total revenues Rs m19,1153,658 522.5%   
Gross profit Rs m3,393811 418.6%  
Depreciation Rs m519105 494.1%   
Interest Rs m9196 95.4%   
Profit before tax Rs m3,377725 465.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m723156 463.3%   
Profit after tax Rs m2,653569 466.3%  
Gross profit margin %18.322.9 80.1%  
Effective tax rate %21.421.5 99.5%   
Net profit margin %14.316.1 89.2%  
BALANCE SHEET DATA
Current assets Rs m16,9972,748 618.6%   
Current liabilities Rs m3,6541,494 244.6%   
Net working cap to sales %72.035.4 203.6%  
Current ratio x4.71.8 252.9%  
Inventory Days Days687 6.5%  
Debtors Days Days821,494 5.5%  
Net fixed assets Rs m5,2462,494 210.3%   
Share capital Rs m45392 492.4%   
"Free" reserves Rs m16,9983,302 514.8%   
Net worth Rs m17,4523,394 514.2%   
Long term debt Rs m0284 0.0%   
Total assets Rs m22,2425,242 424.3%  
Interest coverage x38.08.6 442.7%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.80.7 123.2%   
Return on assets %12.312.7 97.3%  
Return on equity %15.216.8 90.7%  
Return on capital %19.922.3 89.0%  
Exports to sales %039.4 0.0%   
Imports to sales %7.30-   
Exports (fob) Rs mNA1,395 0.0%   
Imports (cif) Rs m1,348NA-   
Fx inflow Rs m6,4911,395 465.3%   
Fx outflow Rs m1,348477 282.5%   
Net fx Rs m5,143918 560.4%   
CASH FLOW
From Operations Rs m2,374161 1,475.3%  
From Investments Rs m-2,592-240 1,081.8%  
From Financial Activity Rs m1,9781 145,462.5%  
Net Cashflow Rs m1,760-77 -2,276.4%  

Share Holding

Indian Promoters % 43.9 57.6 76.2%  
Foreign collaborators % 0.0 9.6 -  
Indian inst/Mut Fund % 20.3 0.0 101,600.0%  
FIIs % 15.6 0.0 155,500.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 56.2 32.8 171.0%  
Shareholders   237,377 11,244 2,111.1%  
Pledged promoter(s) holding % 0.0 2.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MARKSANS PHARMA. With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on MARKSANS PHARMA. vs THEMIS MEDICARE

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

MARKSANS PHARMA. vs THEMIS MEDICARE Share Price Performance

Period MARKSANS PHARMA. THEMIS MEDICARE S&P BSE HEALTHCARE
1-Day -0.13% -0.61% 1.19%
1-Month -1.31% -7.32% -0.74%
1-Year 108.37% -80.03% 61.84%
3-Year CAGR 44.82% -7.66% 18.16%
5-Year CAGR 43.45% -5.80% 19.79%

* Compound Annual Growth Rate

Here are more details on the MARKSANS PHARMA. share price and the THEMIS MEDICARE share price.

Moving on to shareholding structures...

The promoters of MARKSANS PHARMA. hold a 43.9% stake in the company. In case of THEMIS MEDICARE the stake stands at 67.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of MARKSANS PHARMA. and the shareholding pattern of THEMIS MEDICARE.

Finally, a word on dividends...

In the most recent financial year, MARKSANS PHARMA. paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 8.5%.

THEMIS MEDICARE paid Rs 0.5, and its dividend payout ratio stood at 0.8%.

You may visit here to review the dividend history of MARKSANS PHARMA., and the dividend history of THEMIS MEDICARE.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.